Dosis máximas de anestésicos locales - Sociedad de ...

76 REVISTA CHILENA ANESTESIAREFERENCIAS1. Albright GA. Cardiac arrest following regional anesthesia withetidocaine or bupivacaine. Anesthesiology 1979; 51: 285-7.2. Moore DC, Bridenbaugh LD, Thompson GE et al. Factorsdetermining dosages of amide-type local anesthetic drugs.Anesthesiology 1977; 47: 263-8.3. Scott DB. «Maximum recommended doses» of local anaestheticdrugs. Br J Anaesth 1989; 63: 373-4.4. Rosenberg PH, Veering BT, Urmey WF. Maximum recommendeddoses of local anesthetics: a multifactorial concept.Reg Anesth Pain Med 2004; 29: 564-75; discussion 24.5. Safran D, Kuhlman G, Orhant EE et al. Continuous intercostalblockade with lidocaine after thoracic surgery. Clinicaland pharmacokinetic study. Anesth Analg 1990; 70: 345-9.6. Clement R, Malinovsky JM, Le Corre P et al. Cerebrospinalfluid bioavailability and pharmacokinetics of bupivacaineand lidocaine after intrathecal and epiduraladministrations in rabbits using microdialysis. J PharmacolExp Ther 1999; 289: 1015-21.7. Karmakar MK, Ho AM, Law BK et al. Arterial andVenous Pharmacokinetics of Ropivacaine with and withoutEpinephrine after Thoracic Paravertebral Block. Anesthesiology2005; 103: 704-11.8. Palazzo MG, Kalso EA, Argiras E et al. First pass lung uptakeof bupivacaine: effect of acidosis in an intact rabbitlung model. Br J Anaesth 1991; 67: 759-63.9. Tucker GT, Boas RA. Pharmacokinetic aspects of intravenousregional anesthesia. Anesthesiology 1971; 34: 538-49.10. Burm AG, Stienstra R, Brouwer RP et al. Epidural infusionof ropivacaine for postoperative analgesia after majororthopedic surgery: pharmacokinetic evaluation. Anesthesiology2000; 93: 395-403.11. Tucker GT, Mather LE. Clinical pharmacokinetics of localanaesthetics. Clin Pharmacokinet 1979; 4: 241-78.12. McNamara PJ, Alcorn J. Protein binding predictions in infants.AAPS PharmSci 2002; 4: E4.13. Tucker GT, Boyes RN, Bridenbaugh PO, Moore DC.Binding of anilide-type local anesthetics in human plasma.II. Implications in vivo, with special reference to transplacentaldistribution. Anesthesiology 1970; 33: 304-14.14. Meunier JF, Goujard E, Dubousset AM et al. Pharmacokineticsof bupivacaine after continuous epidural infusion in infants withand without biliary atresia. Anesthesiology 2001; 95: 87-95.15. Igarashi T, Hirabayashi Y, Shimizu R et al. The lumbar extraduralstructure changes with increasing age. Br J Anaesth1997; 78: 149-52.16. Kurokawa K, Mimori Y, Tanaka E et al. Age-related change inperipheral nerve conduction: compound muscle action potentialduration and dispersion. Gerontology 1999; 45: 168-73.17. Wing LM, Miners JO, Birkett DJ et al. Lidocaine disposition—sexdifferences and effects of cimetidine. Clin PharmacolTher 1984; 35: 695-701.18. Tucker GT. Properties, absorption, and disposition of local anestheticagents. 3 rd ed.: Lippincott-Raven, Philadelphia, 1998.19. Abernethy DR, Greenblatt DJ. Lidocaine disposition inobesity. Am J Cardiol 1984; 53: 1183-6.20. Butterworth JFt, Walker FO, Lysak SZ. Pregnancy increasesmedian nerve susceptibility to lidocaine. Anesthesiology1990; 72: 962-5.21. Moller RA, Covino BG. Effect of progesterone on thecardiac electrophysiologic alterations produced by ropivacaineand bupivacaine. Anesthesiology 1992; 77:735-41.22. Moller RA, Datta S, Fox J et al. Effects of progesterone onthe cardiac electrophysiologic action of bupivacaine andlidocaine. Anesthesiology 1992; 76: 604-8.23. Pere P, Salonen M, Jokinen M et al. Pharmacokinetics ofropivacaine in uremic and nonuremic patients after axillarybrachial plexus block. Anesth Analg 2003; 96: 563-9,table of contents.24. Mather LE, Copeland SE, Ladd LA. Acute toxicity of localanesthetics: underlying pharmacokinetic and pharmacodynamicconcepts. Reg Anesth Pain Med 2005; 30: 553-66.25. De Jong RH. Local Anesthetics. 1 st ed.: Mosby-YearBook, 1994.26. McEllistrem RF, Schell J, O’Malley K et al. Interscalene brachialplexus blockade with lidocaine in chronic renal failure—a pharmacokinetic study. Can J Anaesth 1989; 36: 59-63.27. Borgeat A, Ekatodramis G, Blumenthal S. Interscalenebrachial plexus anesthesia with ropivacaine 5 mg/mL andbupivacaine 5 mg/mL: effects on electrocardiogram. RegAnesth Pain Med 2004; 29: 557-63.28. Vainionpaa VA, Haavisto ET, Huha TM et al. A clinical andpharmacokinetic comparison of ropivacaine and bupivacainein axillary plexus block. Anesth Analg 1995; 81: 534-8.29. Wank W, Buttner J, Maier KR et al. Pharmacokinetics andefficacy of 40 ml ropivacaine 7.5 mg/ml (300 mg), for axillarybrachial plexus block—an open pilot study. Eur JDrug Metab Pharmacokinet 2002; 27: 53-9.30. Crews JC, Weller RS, Moss J, James RL. Levobupivacaine foraxillary brachial plexus block: a pharmacokinetic and clinicalcomparison in patients with normal renal function or renal disease.Anesth Analg 2002; 95: 219-23, table of contents.31. Burlacu CL, Frizelle HP, Moriarty DC, Buggy DJ. Pharmacokineticsof levobupivacaine, fentanyl, and clonidineafter administration in thoracic paravertebral analgesia.Reg Anesth Pain Med 2007; 32: 136-45.32. Odoom JA, Zuurmond WW, Sih IL et al. Plasma bupivacaineconcentrations following psoas compartment block.Anaesthesia 1986; 41: 155-8.33. Vanterpool S, Steele SM, Nielsen KC et al. Combined lumbarplexusand sciatic-nerve blocks: an analysis of plasma ropivacaineconcentrations. Reg Anesth Pain Med 2006; 31: 417-21.34. Kaloul I, Guay J, Cote C et al. Ropivacaine plasma concentrationsare similar during continuous lumbar plexus blockadeusing the anterior three-in-one and the posterior psoascompartment techniques. Can J Anaesth 2004; 51: 52-6.35. Eljebari H. Comparison of arterial and venous pharmacokineticsof bupivacaine after combined sciatic and lumbarplexus blocks. Reg Anesth Pain Med 2005.36. Farny J, Girard M, Drolet P. Posterior approach to thelumbar plexus combined with a sciatic nerve block usinglidocaine. Can J Anaesth 1994; 41: 486-91.37. Misra U, Pridie AK, McClymont C, Bower S. Plasma concentrationsof bupivacaine following combined sciatic andfemoral 3 in 1 nerve blocks in open knee surgery. Br J Anaesth1991; 66: 310-3.38. Moore DC, Mather LE, Bridenbaugh LD et al. Arterialand venous plasma levels of bupivacaine following peripheralnerve blocks. Anesth Analg 1976; 55: 763-8.39. Agostoni M, Fanelli G, Nobili F et al. [Plasma levels ofmepivacaine in the double block of the sciatic and thefemoral nerve]. Minerva Anestesiol 1992; 58: 281-4.